Cargando…
IDH mutations are enriched in myelodysplastic syndrome patients with severe neutropenia and can be a potential for targeted therapy
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071110/ https://www.ncbi.nlm.nih.gov/pubmed/36420802 http://dx.doi.org/10.3324/haematol.2022.281607 |
| _version_ | 1785019132774711296 |
|---|---|
| author | Komrokji, Rami al Ali, Najla Chan, Onyee Sweet, Kendra Kuykendall, Andrew Lancet, Jeffrey Padron, Eric Sallman, David A. |
| author_facet | Komrokji, Rami al Ali, Najla Chan, Onyee Sweet, Kendra Kuykendall, Andrew Lancet, Jeffrey Padron, Eric Sallman, David A. |
| author_sort | Komrokji, Rami |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10071110 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-100711102023-04-05 IDH mutations are enriched in myelodysplastic syndrome patients with severe neutropenia and can be a potential for targeted therapy Komrokji, Rami al Ali, Najla Chan, Onyee Sweet, Kendra Kuykendall, Andrew Lancet, Jeffrey Padron, Eric Sallman, David A. Haematologica Letter to the Editor Fondazione Ferrata Storti 2022-11-24 /pmc/articles/PMC10071110/ /pubmed/36420802 http://dx.doi.org/10.3324/haematol.2022.281607 Text en Copyright© 2023 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letter to the Editor Komrokji, Rami al Ali, Najla Chan, Onyee Sweet, Kendra Kuykendall, Andrew Lancet, Jeffrey Padron, Eric Sallman, David A. IDH mutations are enriched in myelodysplastic syndrome patients with severe neutropenia and can be a potential for targeted therapy |
| title | IDH mutations are enriched in myelodysplastic syndrome patients with severe neutropenia and can be a potential for targeted therapy |
| title_full | IDH mutations are enriched in myelodysplastic syndrome patients with severe neutropenia and can be a potential for targeted therapy |
| title_fullStr | IDH mutations are enriched in myelodysplastic syndrome patients with severe neutropenia and can be a potential for targeted therapy |
| title_full_unstemmed | IDH mutations are enriched in myelodysplastic syndrome patients with severe neutropenia and can be a potential for targeted therapy |
| title_short | IDH mutations are enriched in myelodysplastic syndrome patients with severe neutropenia and can be a potential for targeted therapy |
| title_sort | idh mutations are enriched in myelodysplastic syndrome patients with severe neutropenia and can be a potential for targeted therapy |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071110/ https://www.ncbi.nlm.nih.gov/pubmed/36420802 http://dx.doi.org/10.3324/haematol.2022.281607 |
| work_keys_str_mv | AT komrokjirami idhmutationsareenrichedinmyelodysplasticsyndromepatientswithsevereneutropeniaandcanbeapotentialfortargetedtherapy AT alalinajla idhmutationsareenrichedinmyelodysplasticsyndromepatientswithsevereneutropeniaandcanbeapotentialfortargetedtherapy AT chanonyee idhmutationsareenrichedinmyelodysplasticsyndromepatientswithsevereneutropeniaandcanbeapotentialfortargetedtherapy AT sweetkendra idhmutationsareenrichedinmyelodysplasticsyndromepatientswithsevereneutropeniaandcanbeapotentialfortargetedtherapy AT kuykendallandrew idhmutationsareenrichedinmyelodysplasticsyndromepatientswithsevereneutropeniaandcanbeapotentialfortargetedtherapy AT lancetjeffrey idhmutationsareenrichedinmyelodysplasticsyndromepatientswithsevereneutropeniaandcanbeapotentialfortargetedtherapy AT padroneric idhmutationsareenrichedinmyelodysplasticsyndromepatientswithsevereneutropeniaandcanbeapotentialfortargetedtherapy AT sallmandavida idhmutationsareenrichedinmyelodysplasticsyndromepatientswithsevereneutropeniaandcanbeapotentialfortargetedtherapy |